Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial

Conditions

• SARS-CoV-2 Infection (COVID-19)

Interventions

• DRUG: (Arm Closed) Nafamostat Mesilate
• DRUG: (Arm Closed) Enoxaparin
• DRUG: (Arm Closed) Dalteparin
• DRUG: (Arm Closed) Tinzaparin
• BIOLOGICAL: (Arm Never Opened) Hyperimmune globulin
• DRUG: Nirmatrelvir-Ritonavir
• DRUG: Remdesivir

Sponsor

University of Melbourne

Collaborators

• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]